Marco Giuseppe Del Buono

Author

Università Cattolica del Sacro Cuore ORCID

Also Known As

M DEL BUONO, M Del Buono, M G Del Buono, M. Buono, M. Del Buono, M.G Del Buono, M.G. Del Buono, MARCO GIUSEPPE DEL BUONO, Marco Giuseppe Del Buono, Marco Buono

209

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore Virginia Commonwealth University Agostino Gemelli University Polyclinic Istituti di Ricovero e Cura a Carattere Scientifico Sapienza University of Rome

About

Marco Giuseppe Del Buono is an author at Università Cattolica del Sacro Cuore specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	303
2	Public Health	7	7	230
3	Health Sciences	2	2	86
4	Education	1	1	15
5	Social Sciences	1	1	15

Marco Giuseppe Del Buono

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction Antonio Abbate, Cory R. Trankle, Leo F. Buckley, Journal of the American Heart Association	2020	281
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure Benjamín W. Van Tassell, Justin M. Canada, Salvatore Carbone, Circulation Heart Failure	2017	232
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction Benjamín W. Van Tassell, Cory R. Trankle, Justin M. Canada, Circulation Heart Failure	2018	202
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse Stefano Toldo, Adolfo G Mauro, Zachary Cutter, Journal of Cardiovascular Pharmacology	2019	136
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials Antonio Abbate, George F. Wohlford, Marco Giuseppe Del Buono, European Heart Journal - Cardiovascular Pharmacotherapy	2021	100
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non‐Obstructive Coronary Arteries: Pathogenic and Prognostic Implications Rocco Antonio Montone, Filippo Luca Gurgoglione, Marco Giuseppe Del Buono, Journal of the American Heart Association	2021	87
Low NT-proBNP Levels in Overweight and Obese Patients Do Not Rule Out a Diagnosis of Heart Failure with Preserved Ejection Fraction Leo F. Buckley, Justin M. Canada, Marco Giuseppe Del Buono, ESC Heart Failure	2018	78
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein Cory R. Trankle, Justin M. Canada, Laura Cei, The American Journal of Cardiology Improve Exercise CapacityHeart FailureCardiovascular DiseaseElevated C-reactive ProteinPhysical Fitness	2018	74
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries Rocco Antonio Montone, Riccardo Rinaldi, Marco Giuseppe Del Buono, EuroIntervention	2022	68
Air Pollution and Coronary Plaque Vulnerability and Instability Rocco Antonio Montone, Massimiliano Camilli, Michele Russo, JACC. Cardiovascular imaging Cardiovascular DiseaseEnvironmental HealthAir QualityAir PollutionPublic Health	2021	58

Page 1